Read + Share
Waterhouse DM, Rothschild S, Dooms C, Mennecier B, et al. Patient-reported outcomes in CodeBreaK 200: Sotorasib versus docetaxel for
previously treated advanced NSCLC with KRAS G12C mutation. Lung Cancer 2024;196:107921.
PMID: 39303400
|
 |
|
Waterhouse DM, Rothschild S, Dooms C, Mennecier B, et al. Patient-reported outcomes in CodeBreaK 200: Sotorasib versus docetaxel for
previously treated advanced NSCLC with KRAS G12C mutation. Lung Cancer 2024;196:107921.
PMID: 39303400
|
|
|
|